Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
240.8 USD | +0.93% | +5.98% | +4.09% |
Apr. 24 | Market Share of Celltrion’s Remsima Rises to 74% in Europe | MT |
Apr. 22 | RBC Cuts Bausch + Lomb Target to US$18, Reiterates Outperform, as Previews Q1 | MT |
Evolution of the average Target Price on Iqvia Holdings Inc.
Price target over the last 5 years
History of analyst recommendation changes
Analysts' Consensus
Consensus detail
Consensus revision (last 18 months)
Analysts covering Iqvia Holdings Inc.
Mizuho Securities | |
Truist Securities | |
Leerink Partners | |
Deutsche Bank Securities | |
UBS | |
Barclays | |
Baird | |
Guggenheim | |
BTIG | |
Citigroup | |
JPMorgan Chase | |
HSBC | |
Stifel Nicolaus | |
Morgan Stanley | |
Wells Fargo Securities | |
Cowen | |
Credit Suisse | |
Evercore ISI | |
Jefferies & Co. | |
Argus | |
SVB Securities LLC | |
Piper Sandler | |
KeyBanc Capital Markets | |
BofA Securities | |
Stephens Inc. |
EPS Revisions
- Stock Market
- Equities
- IQV Stock
- Consensus Iqvia Holdings Inc.